Showing results (41-50 of 142) with videos related to
Sort By:
Pageof 15
Journal of Racial and Ethnic Health Disparities|May 19, 2019
Differences in Breast Cancer Stage at Diagnosis by Ethnicity, Insurance Status, and Family Income in Young Women in the USAMaria Alice Franzoi, Gilberto Schwartsmann, Sérgio Jobim de Azevedo, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 10, 2002
Clinical and pharmacokinetic study of fractionated doses of oral etoposide in pediatric patients with advanced malignanciesLauro J Gregianin, Algemir L Brunetto, Luciane Di Leone, et al.Cancer Treatment Reviews|July 25, 2006
Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectivesTazio Vanni, Eduardo Sprinz, Marcelo Warlet Machado, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 25, 2005
Quantification of the bombesin/gastrin releasing peptide antagonist RC-3095 by liquid chromatography-tandem mass spectrometryAlberto S Pereira, Luciane DiLeone, Fabiano H Souza, et al.European Journal of Pharmacology|January 31, 2004
RC-3095, a bombesin/gastrin-releasing peptide receptor antagonist, impairs aversive but not recognition memory in ratsRafael Roesler, Márcia I Kopschina, Renato M Rosa, et al.Mutation Research|August 6, 2002
Comparative genotoxic effect of vincristine, vinblastine, and vinorelbine in somatic cells of Drosophila melanogasterMarcelo Tiburi, Maria Luiza Reguly, Gilberto Schwartsmann, et al.Peptides|July 19, 2005
Non-associative learning and anxiety in rats treated with a single systemic administration of the gastrin-releasing peptide receptor antagonist RC-3095Márcio Rodrigo Martins, Adalisa Reinke, Samira S Valvassori, et al.Peptides|September 23, 2003
Intrahippocampal infusion of the bombesin/gastrin-releasing peptide antagonist RC-3095 impairs inhibitory avoidance retentionRafael Roesler, Carolina A Meller, Márcia I Kopschina, et al.Expert Review of Anticancer Therapy|November 18, 2010
Current and emerging molecular targets in gliomaRafael Roesler, André T Brunetto, Ana Lucia Abujamra, et al.Oncology|May 10, 2019
Tropomyosin-Related Kinase Receptor and Neurotrophin Expression in Cutaneous Melanoma Is Associated with a Poor Prognosis and Decreased SurvivalLuís Carlos Moreira Antunes, André Cartell, Caroline Brunetto de Farias, et al.Pageof 15